Stephane Jallat
Directeur Financier/CFO chez Piramed Ltd.
Profil
Stephane Jallat has been Finance Director and Controller of Piramed Ltd.
since July 2003.
Prior to joining Piramed, he was Financial Controller Rodaris Pharmaceuticals Ltd.
in 1997.
Previously, Mr. Jallat worked with Arthur Andersen (Barbier Frinault & Associés) from 1991 to 1995.
He received a Master of Economics degree in 1991 from the Essec Business School and a PhD from the University of Paris Pharmaceutical School in 1990.
Postes actifs de Stephane Jallat
| Sociétés | Poste | Début |
|---|---|---|
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Directeur Financier/CFO | 01/07/2003 |
Formation de Stephane Jallat
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
| ESSEC Business School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Commercial Services |
